Table 1.
Group | Weeks post-immunization
|
|||||||
---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | |
pFDNA-LDH@SiO2-NPs IN | 3.333±0.577a | 4.667±0.577a | 6.000±0a | 7.667±0.577a | 8.667±0.577a | 8.667±0.577a | 7.667±1.155a | 7.333±0.577a |
pFDNA-LDH@SiO2-NPs IM | 3.333±0.577a | 4.667±0.577a | 5.000±0a | 5.333 ±1.155b | 7.333±0.577a | 6.333±0.577b | 7.000±0a | 5.667±0.577b |
Naked plasmid pVAX1-F(o) DNA IM | 3.000±1.000a | 4.667±0.577a | 4.667±0.577a | 5.667±0.577b | 3.000±1.000b | 2.667±1.155c | 3.000±1.000b | 3.000±1.000c |
Blank LDH@SiO2-NPs IM | 2.000±1.000b | 1.667±0.577b | 2.000±1.000b | 1.667 ±1.155c | 1.667±1.155c | 2.000±0d | 2.000±1.000b | 1.667±0.577d |
PBS IM | 1.333±0.577b | 1.333±0.577b | 1.667±0.577b | 1.000±0c | 1.333±0.577c | 1.333±0.577d | 1.667±1.155b | 1.000±0d |
Notes: Values are presented as mean ± standard deviation of five experiments in each group. Values within the same column with the different superscript letters are significantly different (P<0.05; Student’s t-test).
Abbreviations: IM, intramuscularly; IN, intranasally; LDH, layered double hydroxide; NPs, nanoparticles; PBS, phosphate-buffered saline; pFDNA-LDH@SiO2-NPs, Newcastle disease virus F gene encapsulated in LDH@SiO2-NPs.